Statistical Considerations for Dominant Lethal Mutagenic Trials
نویسندگان
چکیده
منابع مشابه
Statistical considerations for dominant lethal mutagenic trials.
Statistics can be used in a biological assay as either a method of checking on the validity of conclusions or as a guide to the interpretation of experimental results. The division is sometimes made as one between hypothesis testing and estimation. However, the tool of hypothesis testing can be used as an interpretive aid in conjunction with the tools of estimation, so I prefer to make the divi...
متن کاملThe dominant-lethal test: potential limitations and statistical considerations for safety evaluation.
In June of 1971, two independent labora(acute) and mated with groups of untreated tories under contract with the Food and virgin females over sequential weekly interDrug Administration were given the revals, usually for 8 weeks. In the subacute test sponsibility of determining the potential the male rats are dosed on five consecutive * * 11* St ~~days and then mated. Ten males are genermutageni...
متن کاملAntifertility effects and dominant lethal assays for mutagenic effects of DEHP.
Results of past animal studies have indicated the antifertility effects of phthalate esters and additional studies have suggested the potential mutagenic effects at very high doses. A toxicity study in mice has also been conducted in which chronic LD50 values were calculated for a group of phthalate esters. For DEHP, for example, the acute LD50 was 38.35 ml/kg, but after 10 weeks the value fell...
متن کاملStatistical considerations for stopping systemic lupus erythematosus clinical trials earlier
Group sequential designs are used to potentially shorten randomized clinical trials and thereby reduce subject burden, improve safety, and save time and resources. Clinical trials comparing treatments for systemic lupus erythematosus (SLE) might adopt such designs if the ordinal outcome scales for SLE, such as the Systemic Lupus Activity Measure and Systemic Lupus Erythematosus Disease Activity...
متن کاملStatistical power considerations in genotype-based recall randomized controlled trials
Randomized controlled trials (RCT) are often underpowered for validating gene-treatment interactions. Using published data from the Diabetes Prevention Program (DPP), we examined power in conventional and genotype-based recall (GBR) trials. We calculated sample size and statistical power for gene-metformin interactions (vs. placebo) using incidence rates, gene-drug interaction effect estimates ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Environmental Health Perspectives
سال: 1973
ISSN: 0091-6765
DOI: 10.2307/3428057